{"id":503,"date":"2022-12-22T11:46:53","date_gmt":"2022-12-22T11:46:53","guid":{"rendered":"https:\/\/qa.aliathbio.com\/?post_type=company&#038;p=503"},"modified":"2024-05-13T06:29:20","modified_gmt":"2024-05-13T06:29:20","slug":"ona","status":"publish","type":"company","link":"https:\/\/staging.aliathbio.com\/?company=ona","title":{"rendered":"ONA"},"content":{"rendered":"\n<p>Founded in 2019 in Barcelona, as a spin off from the IRB and ICREA, Ona is developing a new therapeutic approach for the treatment of tumor metastasis based on the inhibition of the receptor CD36.<\/p>\n","protected":false},"featured_media":695,"template":"","tags":[19],"class_list":["post-503","company","type-company","status-publish","has-post-thumbnail","hentry","tag-actived"],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/company\/503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/company"}],"about":[{"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/types\/company"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/media\/695"}],"wp:attachment":[{"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=503"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}